Cardiovascular Disease Doctors in Alexander City, AL Accepting Medicare

4 Cardiovascular Disease doctors found. Showing 1 - 4

Dr. Joseph Arthur Deering, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1649 Highway 22 W, Alexander City, AL 35010 Phone: 256-215-5323    Fax: 256-215-5324

Dr. Basel Alrefai, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 815 Lee St, Alexander City, AL 35010 Phone: 256-212-9300

Dr. Kevin Leonard Sublett, M.D.F.A.C.C. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3368 Highway 280, Suite 130, Alexander City, AL 35010 Phone: 256-234-2644    Fax: 256-234-2704

Dr. Brian A Foley, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1649 Highway 22 W, Alexander City, AL 35010 Phone: 256-215-5323    Fax: 256-215-5323

News Archive

LVNC cardiomyopathy associated with heart failure, stroke and ventricular arrhythmias

Left ventricular non-compaction (LVNC), a cardiomyopathy about which little is fully understood, is associated with heart failure (HF), stroke and ventricular arrhythmias, according to a study to be presented Nov. 17 at the 2010 American Heart Association (AHA) Scientific Sessions in Chicago. The researchers also will report that advanced imaging technologies reveal that developing these cardiac risks appear to progress over time in patients with LVNC.

Congressional briefing to focus on importance of including female subjects in medical research

The Endocrine Society and Society for Women's Health Research are co-sponsoring a Congressional briefing on February 17 that will focus on the importance of including female subjects in both preclinical and clinical biomedical research, which could potentially revolutionize medical research and scientific discovery.

Roche Holdings declares final results of its previously announced tender offer

Roche Holdings, Inc. (the "Offeror") announced today the final results of its previously announced tender offer (the "Offer") to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2.2 billion (the "Maximum Tender Amount") the 5.25% Senior Notes due 2035 issued by the Offeror's subsidiary Genentech, Inc.

Study shows bacille Calmette-Guérin vaccine can protect mice against lethal SARS-CoV-2 challenge

A recent US study, currently available on bioRxiv* preprint server, implies that vaccination with bacille Calmette-Guérin (BCG) can limit the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by targeting innate immune pathways and could thus be used as a platform for pinpointing early immunologic events affecting the outcome of coronavirus disease (COVID-19).

Caltech scientists develop new methods for rapidly determining T cell targets

The human body's immune system is like a vast team of special agents. Certain cells called T cells each individually specialize in recognizing a particular intruder, such as the influenza virus or salmonella.

Read more Medical News

› Verified 6 days ago